Table III.
The indicators of inflammation in the blood of subjects.
| Normal weight (NW) | Overweight ( OW) | Metabolic syndrome (MS) | p* | |||
|---|---|---|---|---|---|---|
| NW-OW | NW-MS | MS-OW | ||||
| Myeloperoxidase (kU/L) | 9.5±1.4 | 18.2±2.4 | 26.5±2.8 | <0.001 | <0.001 | <0.001 |
| Fibrinogen (g/L) | 3.2±0.5 | 3.9±1.1 | 3.6±0.7 | 0.001 | 0.117 | 0.518 |
| Uric acid (mmol/L) | 238.4±72.7 | 239.4±83.3 | 387.6±79.4 | 0.512 | <0.001 | 0.000 |
| SE (mm/h) (median) | 8 (1–36) | 13 (2–48) | 9 (1–42) | 0.007 | 0.338 | 0.559 |
| hsCRP (mg/L) (median) | 0.2 (0.1–0.8) | 1.0 (0.1–4.3) | 1.2 (0.2–3.4) | <0.001 | <0.001 | 0.486 |
Data are presented as mean±SD. p value (p*) refers to the statistical significance of the differences between: normal weight and obese subjects (NW-OW) and normal weight subjects with metabolic syndrome (NW-MS), and obese subjects with metabolic syndrome (MS-OW). The erythrocyte sedimentation rate (SE).